Drug intelligence / Profile preview

Algik

Development stage
Unknown
Lead developer
Laboratórios Azevedos
Modality
Small Molecules
Administration
Oral
01

Overview

Algik is a brand of non-prescription analgesic and antipyretic medications developed and marketed by Laboratórios Azevedos in Portugal. The brand encompasses several distinct small molecule formulations designed for the treatment of mild to moderate pain and fever. These include Ibuprofeno Algik (ibuprofen, available as an oral suspension and 400 mg tablets), Paracetamol Algik (paracetamol, available as an oral solution), and Paracetamol + Cafeína Algik (a combination of paracetamol and caffeine, available as a powder for oral solution). The active ingredients primarily function by inhibiting cyclooxygenase enzymes (COX-1 and COX-2), thereby reducing the synthesis of inflammatory prostaglandins.

Brand names
AlgikIbuprofeno AlgikIbuprofeno Algik 400 MGParacetamol + Cafeína AlgikParacetamol Algik
Other names
ibuprofenparacetamolparacetamol + caffeine
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Algik.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Algik.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call